BioCentury | Jul 17, 2020
Finance

Data Bytes: preclinical IPO performance trending up

...gain of 518%; gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP), at 425%; bispecific mAb company IGM Biosciences Inc....
BioCentury | Jul 10, 2020
Finance

Nkarta’s $252M IPO among biggest preclinical listings ever

...editing play Beam Therapeutics Inc. (NASDAQ:BEAM), went public earlier in 2020, while oncology antibody company IGM Biosciences Inc....
BioCentury | Apr 30, 2020
Product Development

NIH competition to encourage COVID-19 diagnostic innovation, pad U.S. testing capacity

...A different tack on antibodies BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) partnered with Atreca Inc. (NASDAQ:BCEL) and IGM Biosciences Inc....
...crisis can be found at https://www.biocentury.com/coronavirus . Elizabeth S. Eaton, Staff Writer National Institutes of Health BeiGene Ltd. Atreca Inc. IGM Biosciences Inc. Johnson...
BioCentury | Mar 21, 2020
Management Tracks

Kutok joins Epizyme as CSO; plus ADC Therapeutics, Emulate, E-Scape, MiMedx and RubrYc

...Ramesh Baliga as CSO, a newly created position. Baliga was VP of discovery biology at IGM Biosciences Inc....
BioCentury | Dec 6, 2019
Targets & Mechanisms

Bispecifics and allogeneics steal the spotlight from autologous CAR Ts

...a positive control antibody, while producing comparable lysis of CD19-positive lymphoma cells (No. 4070) . IGM Biosciences Inc....
BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...09/18/19 $58.0 $168.5 $186.4 11% Shanghai Henlius Biotech Inc. (HKEX:2696) 09/18/19 $409.9 $3,419.4 $3,341.7 -2% IGM Biosciences Inc....
BioCentury | Sep 23, 2019
Financial News

Fall IPO flurry as biotechs ramp up listing timelines

...a market cap of about $211 million. Underwriters are Cowen, Cantor Fitzgerald and William Blair. IGM Biosciences Inc....
BioCentury | Sep 18, 2019
Financial News

Sept. 18 Financial Quick Takes: IGM gains in first trading day; plus a follow-on roundup, BenevolentAI, UCSF’s InVent Fund and Versantis

...First-day pop for IGM on NASDAQ Oncology antibody company IGM Biosciences Inc. (NASDAQ:IGMS) gained $8.30 (52%) to $24.30...
...Finance. Versantis’ VS-01, a multi-organ supporting therapy for liver disease, is in a first-in-human trial. BC Staff IGM Biosciences Inc. Acadia...
BioCentury | Sep 4, 2019
Financial News

Sept. 4 Financial Quick Takes: BrightGene looks to STAR; plus IPO updates from Immunotech, 10x Genomics, SpringWorks, IGM, Satsuma and more

...and Wedbush PacGrow are underwriters (see "SpringWorks Raises $125M Series B" ). Oncology antibody play IGM Biosciences Inc....
BioCentury | Aug 20, 2019
Financial News

Aug. 19 Financial Quick Takes: Juvenescence raises $100M Series B; plus 10X, IGM propose IPOs

...Watch" ). 10x Genomics, IGM file for NASDAQ listings 10x Genomics Inc. (Pleasanton, Calif.) and IGM Biosciences Inc....
...Piper Jaffray, Stifel and Guggenheim. Elizabeth S. Eaton, Staff Writer and Val Kennedy, Associate Editor 10x Genomics Inc. IGM Biosciences Inc. Juvenescence...
Items per page:
1 - 10 of 14
BioCentury | Jul 17, 2020
Finance

Data Bytes: preclinical IPO performance trending up

...gain of 518%; gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP), at 425%; bispecific mAb company IGM Biosciences Inc....
BioCentury | Jul 10, 2020
Finance

Nkarta’s $252M IPO among biggest preclinical listings ever

...editing play Beam Therapeutics Inc. (NASDAQ:BEAM), went public earlier in 2020, while oncology antibody company IGM Biosciences Inc....
BioCentury | Apr 30, 2020
Product Development

NIH competition to encourage COVID-19 diagnostic innovation, pad U.S. testing capacity

...A different tack on antibodies BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) partnered with Atreca Inc. (NASDAQ:BCEL) and IGM Biosciences Inc....
...crisis can be found at https://www.biocentury.com/coronavirus . Elizabeth S. Eaton, Staff Writer National Institutes of Health BeiGene Ltd. Atreca Inc. IGM Biosciences Inc. Johnson...
BioCentury | Mar 21, 2020
Management Tracks

Kutok joins Epizyme as CSO; plus ADC Therapeutics, Emulate, E-Scape, MiMedx and RubrYc

...Ramesh Baliga as CSO, a newly created position. Baliga was VP of discovery biology at IGM Biosciences Inc....
BioCentury | Dec 6, 2019
Targets & Mechanisms

Bispecifics and allogeneics steal the spotlight from autologous CAR Ts

...a positive control antibody, while producing comparable lysis of CD19-positive lymphoma cells (No. 4070) . IGM Biosciences Inc....
BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...09/18/19 $58.0 $168.5 $186.4 11% Shanghai Henlius Biotech Inc. (HKEX:2696) 09/18/19 $409.9 $3,419.4 $3,341.7 -2% IGM Biosciences Inc....
BioCentury | Sep 23, 2019
Financial News

Fall IPO flurry as biotechs ramp up listing timelines

...a market cap of about $211 million. Underwriters are Cowen, Cantor Fitzgerald and William Blair. IGM Biosciences Inc....
BioCentury | Sep 18, 2019
Financial News

Sept. 18 Financial Quick Takes: IGM gains in first trading day; plus a follow-on roundup, BenevolentAI, UCSF’s InVent Fund and Versantis

...First-day pop for IGM on NASDAQ Oncology antibody company IGM Biosciences Inc. (NASDAQ:IGMS) gained $8.30 (52%) to $24.30...
...Finance. Versantis’ VS-01, a multi-organ supporting therapy for liver disease, is in a first-in-human trial. BC Staff IGM Biosciences Inc. Acadia...
BioCentury | Sep 4, 2019
Financial News

Sept. 4 Financial Quick Takes: BrightGene looks to STAR; plus IPO updates from Immunotech, 10x Genomics, SpringWorks, IGM, Satsuma and more

...and Wedbush PacGrow are underwriters (see "SpringWorks Raises $125M Series B" ). Oncology antibody play IGM Biosciences Inc....
BioCentury | Aug 20, 2019
Financial News

Aug. 19 Financial Quick Takes: Juvenescence raises $100M Series B; plus 10X, IGM propose IPOs

...Watch" ). 10x Genomics, IGM file for NASDAQ listings 10x Genomics Inc. (Pleasanton, Calif.) and IGM Biosciences Inc....
...Piper Jaffray, Stifel and Guggenheim. Elizabeth S. Eaton, Staff Writer and Val Kennedy, Associate Editor 10x Genomics Inc. IGM Biosciences Inc. Juvenescence...
Items per page:
1 - 10 of 14